Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • News

Editor-in-Chief: Giuseppe Leone | Italy

3.3
CiteScore 2024
3.3
CiteScore 2024
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • THE FREQUENCY OF ADRENAL INSUFFICIENCY IN ADOLESCENTS AND YOUNG ADULTS WITH THALASSEMIA MAJOR VERSUS THALASSEMIA INTERMEDIA IN IRAN

    Sara Matin, Masoud Ghanei Jahromi, Zohreh Karemizadeh, Sezaneh Haghpanah, Vincenzo De Sanctis, Ashraf Soliman, Mehran Karimi
    e2015005
    2014-08-28
    https://doi.org/10.4084/mjhid.2015.005
    1951
    PDF: 997
    HTML: 9524
  • EVALUATION OF GLUTATHIONE-S-TRANSFERASE P1 POLYMORPHISM AND ITS RELATION TO BONE MINERAL DENSITY IN EGYPTIAN CHILDREN AND ADOLESCENTS WITH BETA- THALASSEMIA MAJOR

    Seham Ragab
    e2016004
    2016-01-01
    https://doi.org/10.4084/mjhid.2016.004
    3836
    PDF: 812
    HTML: 2409
    Figures: 148
  • STUDY OF SERUM HAPTOGLOBIN LEVEL AND ITS RELATION TO ERYTHROPOIETIC ACTIVITY IN BETA THALASSEMIA CHILDREN .

    Seham Ragab, Manal A. Safan, Eman A. Badr
    e2015019
    2015-02-12
    https://doi.org/10.4084/mjhid.2015.019
    2074
    PDF: 1127
    HTML: 2567
    Study of serum haptoglobin level in thalassemia: 311
    Figures: 155
  • REVIEW AND RECOMMENDATIONS ON MANAGEMENT OF ADULT FEMALE THALASSEMIA PATIE?TS WITH HYPOGONADISM BASED ON LITERATURE REVIEW AND EXPERIENCE OF ICET-A NETWORK SPECIALISTS

    Vincenzo De Sanctis
    e2017001
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.001
    5984
    PDF: 1388
    HTML: 1915
  • RELIABILITY OF DIFFERENT RBC INDICES AND FORMULAS IN DISCRIMINATING BETWEEN ?-THALASSEMIA MINOR AND OTHER CAUSES OF MICROCYTIC HYPOCHROMIC ANEMIA

    Elahe Bordbar, Mehdi Taghipour, Beth E Zucconi
    e2015022
    2015-02-13
    https://doi.org/10.4084/mjhid.2015.022
    1885
    PDF: 1584
    HTML: 14601
    Untitled: 183
    Untitled: 153
  • DETECTION OF ? THALASSEMIA CARRIERS BY RED CELL PARAMETERS OBTAINED FROM AUTOMATIC COUNTERS USING MATHEMATICAL FORMULAS

    Idit Lachover Roth, Boaz Lachover, Guy Koren, Carina Levin, Luci Zalman, Ariel Koren
    e2018008
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.008
    4661
    PDF: 1644
    HTML: 1036
  • EARLY PREDICTORS OF RENAL DYSFUNCTION IN ?-THALASSEMIA MAJOR AND INTERMEDIA PATIENTS

    Azza A.G. Tantawy, Nagham El Bablawy, Amira A. M Adly, Fatma S E Ebeid
    e2014057
    2004-09-01
    https://doi.org/10.4084/mjhid.2014.057
    1858
    PDF: 904
    HTML: 3745
  • INSULIN-LIKE GROWTH FACTOR-1 (IGF-1): DEMOGRAPHIC, CLINICAL AND LABORATORY DATA IN 120 CONSECUTIVE ADULT PATIENTS WITH THALASSAEMIA MAJOR

    V. De Sanctis
    e2014.074
    2014-11-01
    https://doi.org/10.4084/mjhid.2014.074
    2164
    PDF: 906
    HTML: 26908
  • GENETIC HETEROGENEITY OF BETA GLOBIN MUTATIONS AMONG ASIAN-INDIANS AND IMPORTANCE IN GENETIC COUNSELLING AND DIAGNOSIS

    Ravindra Kumar, Kritanjali Singh, Inusha Panigrahi, Sarita Agarwal
    e2013003
    2013-01-01
    https://doi.org/10.4084/mjhid.2013.003
    1694
    PDF: 1245
    HTML: 11427
    Figure1: 147
    Figure 2: 153
  • ?-THALASSEMIA DISTRIBUTION IN THE OLD WORLD: A HISTORICAL STANDPOINT OF AN ANCIENT DISEASE

    Vincenzo De Sanctis
    e2017018
    2017-02-20
    https://doi.org/10.4084/mjhid.2017.018
    10771
    PDF: 4190
    HTML: 4307
  • CLINICAL AND BIOCHEMICAL DATA OF ADULT THALASSEMIA MAJOR PATIENTS (TM) WITH MULTIPLE ENDOCRINE COMPLICATIONS (MEC) VERSUS TM PATIENTS WITH NORMAL ENDOCRINE FUNCTIONS: A RETROSPECTIVE LONG-TERM STUDY (40 YEARS) IN A TERTIARY CARE CENTER IN ITALY

    Vincenzo De Sanctis, Heba Elsedfy
    e2016022
    2016-04-12
    https://doi.org/10.4084/mjhid.2016.022
    3637
    PDF: 974
    HTML: 3470
  • ACQUIRED HYPOGONADOTROPIC HYPOGONADISM (AHH) IN THALASSAEMIA MAJOR PATIENTS: AN UNDERDIAGNOSED CONDITION?

    Vincenzo De Sanctis
    e2016001
    2016-01-01
    https://doi.org/10.4084/mjhid.2016.001
    5013
    PDF: 1248
    HTML: 3546
  • HEMOGLOBIN ANALYSIS IN THE FIRST YEAR OF LIFE

    PEERAPON WONG
    e2016012
    2016-02-12
    https://doi.org/10.4084/mjhid.2016.012
    3364
    PDF: 975
    HTML: 3003
  • Late-onset male hypogonadism and fertility potential in thalassemia major patients: Two emerging issues

    Vincenzo De Sanctis
    e2015047
    2015-07-08
    https://doi.org/10.4084/mjhid.2015.047
    1724
    PDF: 889
    HTML: 761
  • EXERCISE STRESS ECHOCARDIOGRAPHY WITH TISSUE DOPPLER IMAGING (TDI) DETECTS EARLY SYSTOLIC DYSFUNCTION IN BETA-THALASSEMIA MAJOR PATIENTS WITHOUT CARDIAC IRON OVERLOAD

    Umberto Barbero
    e2012037
    2012-06-14
    https://doi.org/10.4084/mjhid.2012.037
    1240
    PDF: 764
    HTML: 7859
    Manuscript after revision: 223
    Barbero10328-36310-after revision: 209
  • PREDISPOSING FACTORS TO INFECTIONS IN THALASSEMIA SYNDROME PATIENTS

    Eman M Mansory, Lina M. Abdulrahman, Balsam Osman, Sawsan M. Sawsan, Assil F. Ruckn, Marwa Aljedaani, Nemmat Hassan, Ahmed S. Barefah, Hatem M. Alahwal, Yassir Daghistani, Salem M. Bahashwan, Abdullah T. Almohammadi, Osman O. Radhwi
    e2025055
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.055
    1313
    PDF: 926
    HTML: 292
  • VASCULAR ENDOTHELIAL GROWTH FACTOR IN CHILDREN WITH THALASSEMIA MAJOR PDF

    sameh samir fahmey, Hassan Naguib, sanna Abdelshafy, rasha Alashry
    e2013044
    2013-06-05
    https://doi.org/10.4084/mjhid.2013.044
    1227
    PDF: 807
    HTML: 1022
    Figure 1 the correlation between frequency of blood transfusion and serum vascular endothelial growth factor (VEGF).: 150
  • A MULTICENTER ICET-A SURVEY ON ADHERENCE TO ANNUAL ORAL GLUCOSE TOLERANCE TEST (OGTT) SCREENING IN TRANSFUSION-DEPENDENT THALASSEMIA (TDT) PATIENTS - THE EXPERT CLINICIANS’ OPINION ON FACTORS INFLUENCING THE ADHERENCE AND ON ALTERNATIVE STRATEGIES FOR ADHERENCE OPTIMIZATION Survey on adherence to annual OGTT in thalassemia

    Vincenzo De Sanctis
    e2025008
    2024-12-31
    https://doi.org/10.4084/MJHID.2025.008
    2777
    PDF: 1268
    HTML: 148
  • QUALITY OF LIFE IN PATIENTS WITH THALASSEMIA MAJOR AND INTERMEDIA IN KERMAN-IRAN (I.R.)

    Hossein Safizadeh, Zahra Farahmandinia, Simin Soltani nejad, Nasim Pourdamghan, Majid Araste
    e2012058
    2012-10-03
    https://doi.org/10.4084/mjhid.2012.058
    1588
    PDF: 713
    HTML: 2322
    Cover Letter: 152
  • THE ICET-A RECOMMENDATIONS FOR THE DIAGNOSIS AND MANAGEMENT OF DISTURBANCES OF GLUCOSE HOMEOSTASIS IN THALASSEMIA MAJOR PATIENTS

    Vincenzo De Sanctis
    e2016058
    2016-10-25
    https://doi.org/10.4084/mjhid.2016.058
    4118
    PDF: 1132
    HTML: 1153
  • CARDIAC FUNCTION AND IRON CHELATION IN THALASSEMIA MAJOR AND INTERMEDIA: A REVIEW OF THE UNDERLYING PATHOPHYSIOLOGY AND APPROACH TO CHELATION MANAGEMENT

    Athanasios Aessopos, Vasilios Berdoukas
    e2009002
    2009-07-18
    1507
    PDF: 461
    HTML: 1423
  • SALIVA IRON AND FERRITIN LEVELS IN PATIENTS WITH THALASSEMIA AND IRON DEFICIENCY ANEMIA

    Duran Canatan, Sevgi Kosaci Akdeniz
    e2012051
    2012-08-09
    https://doi.org/10.4084/mjhid.2012.051
    2790
    PDF: 1426
    HTML: 10858
  • THE ICET-A SURVEY ON CURRENT CRITERIA USED BY CLINICIANS FOR THE ASSESSMENT OF CENTRAL ADRENAL INSUFFICIENCY IN THALASSEMIA: ANALYSIS OF RESULTS AND RECOMMENDATIONS

    Vincenzo De Sanctis
    e2016034
    2016-07-01
    https://doi.org/10.4084/mjhid.2016.034
    3547
    PDF: 835
    HTML: 1713
  • LONG-TERM EFFECTIVENESS, SAFETY, AND TOLERABILITY OF TWICE-DAILY DOSING WITH DEFERASIROX IN CHILDREN WITH TRANSFUSION-DEPENDENT THALASSEMIAS UNRESPONSIVE TO STANDARD ONCE-DAILY DOSING

    Jassada Buaboonnam, Chayamon Takpradit, Vip Viprakasit, Nattee Narkbunnam, Nassawee Vathana, Kamon Phuakpet, Kleebsabai Sanpakit, Bunchoo Pongtanakul
    e2021065
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.065
    1042
    PDF: 380
    HTML: 139
  • IRON CHELATION THERAPY IN THALASSEMIA SYNDROMES

    Paolo Cianciulli
    e2009034
    1181
    PDF: 595
    HTML: 2288
  • GLUCOSE HOMEOSTASIS AND ΑSSESSMENT OF Β-CELL FUNCTION BY 3-HOUR ORAL GLUCOSE TOLERANCE (OGTT) IN PATIENTS WITH Β-THALASSEMIA MAJOR WITH SERUM FERRITIN BELOW 1,000 NG/DL: RESULTS FROM A SINGLE ICET-A CENTRE OGTT in thalassemia and iron overload

    Vincenzo De Sanctis, Ashraf Soliman, Shahina Daar, Ploutarchos Tzoulis , Salvatore Di Maio, Christos Kattamis
    e2023006
    2023-01-01
    https://doi.org/10.4084/MJHID.2023.006
    3787
    PDF: 1046
    HTML: 403
  • THERAPEUTIC VALUE OF COMBINED THERAPY WITH DEFERASIROX AND SILYMARIN ON IRON OVERLOAD IN CHILDREN WITH BETA THALASSEMIA

    adel abd elhaleim hagag
    e2013065
    2013-11-04
    https://doi.org/10.4084/mjhid.2013.065
    2469
    PDF: 792
    HTML: 14923
    Therapeutic Value of Combined Therapy with Deferasirox and Silymarin on Iron Overload in Children with Beta Thalassemia: 259
  • GLUCOSE METABOLISM AND INSULIN RESPONSE TO ORAL GLUCOSE TOLERANCE TEST (OGTT) IN PREPUBERTAL PATIENTS WITH TRANSFUSION DEPENDENT Β-THALASSEMIA (TDT): A LONG-TERM RETROSPECTIVE ANALYSIS Long-term retrospective analysis of glucose homeostasis in children with transfusion dependent β-thalassemia

    Vincenzo De Sanctis, Ashraf Soliman, Ploutarchos Tzoulis, Shahina Daar, Salvatore Di Maio, Bernadette Fiscina, Christos Kattamis
    e2021051
    2021-08-28
    https://doi.org/10.4084/MJHID.2021.051
    1475
    PDF: 491
    HTML: 147
  • PRENATAL DIAGNOSIS OF ?-THALASSEMIAS AND HEMOGLOBINOPATHIES

    Maria Cristina Rosatelli, Luisella Saba
    e2009011
    2009-11-15
    1147
    PDF: 354
    HTML: 6341
  • Epidemiological surveillance of SARSCov2 in β-Thalassemia Patients in the last two years: reinfection rate, insights and future challenges

    Lorenza Torti, Francesco Sorrentino, Laura Maffei, Paolo De Fabritiis, Elisabetta Abruzzese
    e2023007
    2023-01-01
    https://doi.org/10.4084/MJHID.2023.007
    798
    PDF: 888
    HTML: 377
  • ROLE OF STEM CELL FACTOR IN THE REACTIVATION OF HUMAN FETAL HEMOGLOBIN

    Marco Gabbianelli, Ugo Testa
    e2009009
    2009-11-12
    1050
    PDF: 459
    HTML: 4466
  • Elevated endogenous alveolar carbon monoxide concentration in patients with transfusion-dependent thalassemia and its relation to ineffective erythropoiesis

    Yanni Xie
    e2025047
    2025-06-29
    https://doi.org/10.4084/MJHID.2025.047
    519
    PDF: 393
    HTML: 18
  • RECENT INSIGHTS INTO THE POPULATION GENETICS AND DYNAMICS OF THE INHERITED DISORDERS OF HEMOGLOBIN

    David J Weatherall
    e2009022
    2009-12-20
    1011
    PDF: 438
    HTML: 516
  • COMPARATIVE STUDY ON THE MEASUREMENT OF LIVER T2* VALUES OF THALASSEMIA PATIENTS AND THE CLINICAL GRADING OF LIVER IRON CONCENTRATION BY DIFFERENT POST-PROCESSING SOFTWARE MEASUREMENT OF LIVER T2* VALUES OF THALASSEMIA

    Peng Peng, Fengming XU, Jixing YI, Bumin LIANG, Cheng TANG, Qing FENG
    e2022072
    2022-10-29
    https://doi.org/10.4084/MJHID.2022.072
    731
    PDF: 543
    HTML: 185
  • INFECTIONS IN THALASSEMIA AND HEMOGLOBINOPATHIES

    Bianca Maria Ricerca, Arturo Di Girolamo, Deborah Rund
    e2009028
    2009-12-28
    1033
    PDF: 588
    HTML: 4260
  • IN UTERO HAEMATOPOIETIC STEM CELL TRANSPLANTATION (IUHSCT)

    Maria Concetta Renda, Aurelio Maggio
    e2009031
    2009-12-29
    1028
    PDF: 444
    HTML: 868
  • Identification of Alpha Thalassemia, RNF 213 p.R4810K and PROC p.R189W among Children with Moyamoya Disease/Syndrome Alpha Thalassemia and RNF 213 Gene Mutation in Moyamoya

    Lunliya Thampratankul, Yusuke Okuno, Patcharee Komvilaisak, Duangrurdee Wattanasirichaigoon, Nongnuch Sirachainan
    e2022057
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.057
    867
    PDF: 644
    HTML: 208
  • COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES

    M. Domenica Cappellini, Khaled M. Musallam, Alessia Marcon, Ali Taher
    e2009029
    2009-12-28
    1029
    PDF: 465
    HTML: 8132
  • THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES Gene therapy for Hemoglobinopathies.

    Ugo Testa, Giuseppe Leone, Prof. M.D. Cappellini
    e2024068
    2024-08-31
    https://doi.org/10.4084/MJHID.2024.068
    1957
    PDF: 1153
    Html: 254
  • VITAMIN D STATUS IN THALASSEMIA MAJOR: AN UPDATE

    Ashraf Tawfik Soliman
    e2013057
    2013-09-02
    https://doi.org/10.4084/mjhid.2013.057
    2539
    PDF: 1036
    HTML: 2529
  • HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA AND SICKLE CELL DISEASE: EXPERIENCE OF MEDITERRANEAN INSTITUTE OF HEMATOLOGY IN A MULTI-ETHNIC POPULATION.

    Marco Marziali, Antonella Isgrò, Javid Gaziev, Guido Lucarelli
    e2009027
    2009-12-26
    1613
    PDF: 700
    HTML: 2900
  • Concordance Rate of Fasting Plasma Glucose (PG) and 2-hour PG post Oral Glucose Tolerance Test (OGTT) in Patients with new diagnosis of Thalassemia-Related Diabetes Mellitus (Th-RDM):Implications for Clinical Practice OGTT concordance rate in thalassemia major

    Vincenzo De Sanctis, Mohammad Faranoush, Shahina Daar, Ihab Elhakim, Ashraf T Soliman, Forough Saki, Mehran Karimi, Ploutarchos Tzoulis
    e2026011
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.011
    489
    PDF: 342
    Html: 91
  • LONGITUDINAL STUDY ON LIVER FUNCTIONS IN PATIENTS WITH THALASSEMIA MAJOR BEFORE AND AFTER DEFERASIROX (DFX) THERAPY

    Ashraf Tawfik Soliman, Mohamed Yassin, Fawzia AlYafei, Lolwa Al-Naimi, Noora Almarri, Aml Sabt, Vincenzo De Sanctis
    e2014025
    2014-04-06
    https://doi.org/10.4084/mjhid.2014.025
    2108
    PDF: 2090
    HTML: 2399
  • The correlation between ineffective erythropoiesis biomarkers and development of extramedullary hematopoiesis in patients with thalassemia

    Siriyakorn Chansai, Supawadee Yamsri, Supan Fucharoen, Goonnapa Fucharoen, Nattiya Teawtrakul
    e2022052
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.052
    990
    PDF: 439
    HTML: 198
  • THALASSAEMIA AND ABERRATIONS OF GROWTH AND PUBERTY

    Andreas Kyriakou, Nicos Skordis
    e2009003
    2009-07-28
    1053
    PDF: 446
    HTML: 3201
  • JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia

    Phakatip Sinlapamongkolkul, Pacharapan Surapolchai, Vip Viprakasit
    e2023056
    2023-08-29
    https://doi.org/10.4084/MJHID.2023.056
    1911
    PDF: 570
    Suppl. Files: 263
    HTML: 148
  • END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRASFUSION DEPENDEND-β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATION Challenges in Supportive Care, Equity, and Compassion at End of Life

    Dr. Sophia Delicou, Dr Katerina Xydaki, Dr Maria Moraki, Dr Theodoros Aforozis
    e2026015
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.015
    857
    PDF: 496
    Html: 140
  • PREVENTION OF ? THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS.

    Ariel Koren, Lora Profeta, Luci Zalman, Haya Palmor, Carina Levin, Ronit Bril Zamir, Stavit Shalev, Orna Blondheim
    e2014012
    2014-02-17
    https://doi.org/10.4084/mjhid.2014.012
    2392
    PDF: 1112
    HTML: 11770
  • THE EFFECT OF ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS IN IBADAN, NIGERIA. ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS

    FASOLA ATINUKE
    e2022001
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.001
    2130
    PDF: 908
    HTML: 55
  • PREVALENCE OF THALASSEMIA IN THE VIETNAMESE POPULATION AND BUILDING A CLINICAL DECISION SUPPORT SYSTEM FOR PRENATAL SCREENING FOR THALASSEMIA

    Danh Cuong Tran, Anh Linh Dang, Thi Ngoc Lan Hoang, Chi Thanh Nguyen, Thi Ngoc Mai Dinh, Van Anh Tran, Thi Kim Phuong Doan, Thi Trang Nguyen
    e2023026
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.026
    1637
    HTML: 250
    PDF: 1125
1 - 50 of 52 items 1 2 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy